Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9387f04a5bc9066136103e452e8d1e1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
filingDate |
2006-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f5aedcacec51732692e1cb375b31ec2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5424cd559bf7e6bc12900b7d756a5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5664caf32f77eb3221f46a9e6b5d67ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a70248deb36122e25d6d1ae3483693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbda5f3705a750b5c4761f1165af052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff2e2a428091b8a4592cd0edd552b935 |
publicationDate |
2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2248532-A1 |
titleOfInvention |
Protein kinase modulation by hops and acacia products cross-reference to related applications |
abstract |
An aspect of the invention comprises a composition for modulating the activity of a plurality of disease associated protein kinases in a subject in need thereof, wherein said protein kinase modulation is beneficial to the health of the subject; said composition comprising a therapeutically effective amount of a composition comprising reduced isoalpha acids and a compound or extract derived from acacia. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105963291-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105963291-B |
priorityDate |
2005-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |